Serum S100B levels in patients with lupus erythematosus: Preliminary observation

Clinical and Diagnostic Laboratory Immunology

Volumn 9, Issue 1, 2002, Pages 164-166

  Portela, Luis V C ^a   Brenol, João C T ^a   Walz, Roger ^a   Bianchin, Marino ^a   Tort, Adriano B L ^a   Canabarro, Ubirajara P ^a   Beheregaray, Simone ^a   Marasca, João A ^a   Xavier, Ricardo M ^a   Neto, Eurico C ^a   Gonçalves, Carlos A ^a   Souza, Diogo O ^a  

^a Instituto de Ciencias Biologicas e da Saude Pontifical Catholic University of Minas Gerais   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CALCIUM BINDING PROTEIN; PROTEIN S100B;

ADULT; ARTICLE; BRAIN DYSFUNCTION; BRAIN INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; IMMUNOASSAY; LUMINESCENCE; MALE; MENTAL DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; CALCIUM-BINDING PROTEINS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; S100 PROTEINS;

EID: 0036146142     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.9.1.164-166.2002     Document Type: Article

References (24)

1. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes
2. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type
3. Elevated S100 blood level as an early indicator of intraventricular hemorrhage in preterm infants. Correlation with cerebral Doppler velocimetry
4. Extracellular S100B protein modulates ERK in astrocyte cultures
5. Ca2+-binding S100 proteins in the central nervous system
6. Increased serum concentration of protein S-100 after minor head injury: A biochemical serum marker with prognostic value?
7. Traumatic brain damage in minor head injury: Relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioural outcome
8. Significance of serum S100 release after coronary artery bypass grafting
9. Definition, classification, activity and damage indices
10. Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematous patients without overt central nervous system disease
11. Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurological disorders
12. Increased serum S100B protein in schizophrenia: A study in medication-free patients
13. Dexamethasone regulates basic fibroblast growth factor, nerve growth factor and S100beta expression in cultured hippocampal astrocytes
14. Asymptomatic cerebrovascular lesions detected by magnetic resonance imaging in patients with systemic lupus erythematosus lacking a history of neuropsychiatric events
15. Central nervous system involvement in systemic lupus erythematous patients without overt neuropsychiatric manifestations
16. Central nervous system involvement in systemic lupus erythematosus: Cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations
17. Human brain S100B and S100B mRNA expression increases with age: Pathogenic implications for Alzheimer's disease
18. Neurometabolism of active neuropsychiatric lupus determined by proton MR spectroscopy
19. Glial cytokines as neuropathogenic factors in HIV infection: Pathogenic similarities to Alzheimer's disease
20. Interleukin-1 and interleukin-6 activities are increased in cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T-cell activation markers
21. Serum S100B levels in patients with HTLV-I associated myelopathy/tropical spastic paraparesis
22. Effect of dexamethasone on glutamine synthetase and glial fibrillary acidic protein in normal and transformed astrocytes
23. S100beta release in hypothermic circulatory, arrest and coronary, artery, surgery
24. Early neurobehavioural outcome after stroke is related to release of neurobiochemical markers of brain damage